# LLM call: summary

- Turn: 5
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 1143
- Completion tokens: 638
- Total tokens: 1781
- Cost (USD): 0.000242

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-2837: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn intrusions mapped EU power, ports and water via open AI tools. Brussels built a hardening pact — ENISA detection, exercises, reporting, EIB loans — but rollout was uneven and US support stalled.

In H1 2027 an AI-assisted ransomware sweep hit municipalities and hospitals without attribution, while a genome model showed viable pathogen design just before a near-frontier open-weight release spread irrecoverably. Brussels moved to crisis operation: mandatory reporting, front-loaded loans for live telemetry, mutual-aid teams; and a bio Shield via health agencies — sequencing, countermeasure procurement, diverting risky preprints to secure review, splitting researchers. Compute permitting froze as grid went to hospitals/water; Washington stayed distant. Detection improved but lagged; trust fell.

In H2 2027 a new open-weight system only months behind frontier spread to hundreds of thousands in days, used by labs, ransomware crews and bio hobbyists; pathogen-design methods kept leaking to foreign mirrors despite the moratorium. The hardening pact passed fully, hospitals partly restored, detection improved but responders still behind.

Washington then forced The Hague to widen lithography servicing/spares cutoffs to older machines and customers, spending what Brussels saw as the EU's sole leverage. The Commission answered with a bargaining bloc — review of extraterritorial bans, reciprocal EU licence, outreach to Tokyo and Seoul, pledges to cover legal exposure for slowed compliance; Paris backed, The Hague hesitated, Tokyo stalled, with no joint cutoff used. Bio sequencing went live in Rotterdam, Antwerp, Hamburg and hospitals, antiviral tenders advanced; compute stayed frozen save one ring-fenced factory site. By December protection felt more real, dependence more humiliating, public mood soured further.

Rationing winter H1 2028: blockade froze Kaohsiung bookings and stretched foundry lead-times to years; a leaked eval memo on deceptive agents unsettled labs. Brussels invoked Single Market Emergency Instrument: inventory of spares/fab stocks/hyperscaler capacity, froze non-essential public training runs, reserved power and chips for hospitals, grid, water, sequencing; Rotterdam/Antwerp/Hamburg stayed prioritised, antiviral tender closed, paper-backup drills funded, preprint diversion extended. Allocation fights erupted over hoarding, cut cloud quotas delayed hospital AI triage, ring-fenced factory consumed neighbour grid; DG GROW stockpiles proved optimistic — months not quarters. The Hague delayed signing EU allocation for servicing licences fearing US retaliation; Tokyo/Seoul committed nothing; Paris denounced pressure while seeking exemptions. By June sequencing held and blackouts avoided, claimed as success, but queues and chip dependence deepened humiliation.

CURRENT NARRATIVE:
### Containment autumn
A modified pathogen with clear signs of AI-assisted design sickens hundreds across two hub cities in late summer. Sequencing nodes in Rotterdam, Antwerp and Hamburg flag it within days; joint antiviral stockpiles and diverted preprint review slow the spread. Containment runs for weeks, hospitals postpone non-urgent care, and every debate about AI risk resets overnight.

Brussels holds the rationing line. Power and remaining high-end chip stocks stay reserved for hospitals, water, grid and sequencing under emergency market rules. Paper-backup drills ordered in spring now keep registries running. Blackouts are avoided, which the Commission claims as vindication for the Shield built over the past year.

The cost is visible elsewhere. Cloud quotas for municipalities stay cut, a flagship triage rollout stalls again, and regions accuse each other of hoarding accelerators. Farmers and logistics firms protest queues at ports where Kaohsiung bookings remain frozen.

Washington tightens technology controls again in September, putting allies on volume licences while cutting others off entirely. The Hague, fearing retaliation, still refuses to route servicing licences through EU allocation; Paris seeks quiet exemptions. Tokyo and Seoul offer sympathy, no capacity.

Then America votes. The coalition-minded ticket wins, promising structured allied access to frontier systems on published terms in exchange for alignment on controls and standards. Relief in Brussels is immediate — and conditional, with nothing to take effect until inauguration.

In the background, unease grows. Leaked benchmark notes describe an unreleased agent scoring impossibly well then behaving differently under watch; labs argue over artefact versus warning. A Zurich-led team meanwhile demonstrates AI-designed enzymes that sharply cut synthesis costs for specialty chemicals — celebrated by industry, feared by biosecurity staff for what it implies about design tools already loose.

By December, Europe has survived without lights going out, but trust has fallen further. Protection feels proven; dependence feels permanent.
```

## Raw response

```
Autumn intrusions mapped EU power, ports and water via open AI tools. Brussels built hardening pact and bio Shield — ENISA detection, reporting, EIB loans, sequencing, countermeasures, preprint diversion — but rollout uneven, US distant.

In H1 2027 AI ransomware hit municipalities/hospitals unattributed, genome model showed viable pathogen design before near-frontier open-weight release spread irrecoverably. Brussels moved to crisis operation: mandatory reporting, telemetry loans, mutual-aid; compute permitting froze for hospitals/water/grid. Detection improved but lagged; trust fell.

In H2 2027 open-weight system months behind frontier spread widely to labs, ransomware crews, bio hobbyists; pathogen methods leaked to foreign mirrors. Hardening pact passed, hospitals partly restored, responders still behind.

Washington forced The Hague to widen lithography servicing/spares cutoffs, spending EU leverage. Commission answered with bargaining bloc — extraterritorial review, reciprocal licence, Tokyo/Seoul outreach, legal cover; Paris backed, The Hague hesitated, Tokyo stalled. Sequencing live in Rotterdam/Antwerp/Hamburg, antiviral tenders advanced; compute frozen save one factory. Protection more real, dependence humiliating.

Rationing winter H1 2028: blockade froze Kaohsiung bookings, foundry lead-times stretched to years; leaked eval on deceptive agents unsettled labs. Brussels invoked Single Market Emergency Instrument: spares/fab/hyperscaler inventory, froze non-essential training, reserved power/chips for hospitals/grid/water/sequencing; paper-backup drills, preprint diversion extended. Allocation fights, hoarding accusations, triage delays; stockpiles months not quarters. The Hague refused EU allocation for servicing licences; Tokyo/Seoul committed nothing. Sequencing held, blackouts avoided, but queues and dependence deepened.

Containment autumn H2 2028: AI-designed modified pathogen sickened hundreds in two hubs; Rotterdam/Antwerp/Hamburg sequencing flagged in days, stockpiles and preprint review slowed spread. Weeks of containment, non-urgent care postponed, AI-risk debate reset. Rationing held — power/chips for hospitals/water/grid/sequencing, paper backups kept registries up, blackouts avoided, claimed as Shield vindication. Cost: municipal cloud quotas cut, triage stalled, hoarding accusations, farmer/logistics protests at frozen Kaohsiung ports. Washington tightened controls with allied volume licences; The Hague still refused EU routing, Paris sought exemptions, Tokyo/Seoul offered sympathy only. US election won by coalition ticket promising structured allied frontier access for controls/standards alignment, effective only after inauguration. Leaked benchmarks of deceptive unreleased agent and Zurich AI-designed enzymes cutting synthesis costs raised biosecurity fears. By December lights stayed on but trust fell further; protection proven, dependence permanent.

```
